DK0826681T3 - Epoxyravsyrederivater - Google Patents
EpoxyravsyrederivaterInfo
- Publication number
- DK0826681T3 DK0826681T3 DK96907747T DK96907747T DK0826681T3 DK 0826681 T3 DK0826681 T3 DK 0826681T3 DK 96907747 T DK96907747 T DK 96907747T DK 96907747 T DK96907747 T DK 96907747T DK 0826681 T3 DK0826681 T3 DK 0826681T3
- Authority
- DK
- Denmark
- Prior art keywords
- aralkyl
- alkyl
- acid derivatives
- epoxysuccinic acid
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10050495 | 1995-03-31 | ||
| PCT/JP1996/000889 WO1996030354A1 (fr) | 1995-03-31 | 1996-04-01 | Derives d'acide epoxysuccinique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0826681T3 true DK0826681T3 (da) | 2003-02-17 |
Family
ID=14275780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96907747T DK0826681T3 (da) | 1995-03-31 | 1996-04-01 | Epoxyravsyrederivater |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5843992A (pt) |
| EP (1) | EP0826681B1 (pt) |
| KR (1) | KR100381275B1 (pt) |
| CN (1) | CN1087295C (pt) |
| AT (1) | ATE225781T1 (pt) |
| AU (1) | AU716620B2 (pt) |
| CA (1) | CA2217051C (pt) |
| DE (1) | DE69624235T2 (pt) |
| DK (1) | DK0826681T3 (pt) |
| EA (1) | EA000438B1 (pt) |
| ES (1) | ES2184855T3 (pt) |
| PT (1) | PT826681E (pt) |
| WO (1) | WO1996030354A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998000422A1 (en) * | 1996-07-02 | 1998-01-08 | Sang Sup Jew | Oxirane carboxylic acid derivative and its manufacturing method |
| PL335478A1 (en) * | 1997-02-26 | 2000-04-25 | Lilly Co Eli | Method of obtaining pharmaceutic compounds |
| AU8997898A (en) | 1997-09-04 | 1999-03-22 | Nippon Chemiphar Co. Ltd. | Epoxysuccinamide derivatives |
| US20070203073A1 (en) * | 2005-06-22 | 2007-08-30 | Diamond Scott L | SARS and Ebola inhibitors and use thereof, and methods for their discovery |
| US20080227806A1 (en) * | 2005-09-28 | 2008-09-18 | American Life Science Pharmaceuticals | Novel Drugs for Dementia |
| JP2010503610A (ja) * | 2006-05-22 | 2010-02-04 | ベルキュラ セラピューティクス インコーポレイティッド | 骨産生におけるカテプシンｋアンタゴニストの使用 |
| US20100216875A1 (en) * | 2006-12-20 | 2010-08-26 | Gregory Hook | Methods of treating alzheimer's disease |
| EP2168600A1 (en) | 2007-06-08 | 2010-03-31 | Nippon Chemiphar Co., Ltd. | Therapeutic or prophylactic agent for cerebral aneurysm |
| US20100331545A1 (en) | 2007-10-24 | 2010-12-30 | Nippon Chemiphar Co., Ltd. | Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| RU2756956C2 (ru) * | 2020-03-26 | 2021-10-07 | Публичное акционерное общество «СИБУР Холдинг» | Способ получения кристаллической формы цис-2,3-эпоксисукцината кальция |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5547668A (en) * | 1978-09-30 | 1980-04-04 | Taisho Pharmaceut Co Ltd | Epoxysuccinamic acid |
| US4418705A (en) * | 1979-05-22 | 1983-12-06 | G. D. Societa Per Azioni | Method and relative manufacturing machine for simultaneously producing two continuous cigarette rods |
| EP0269311A3 (en) * | 1986-11-17 | 1990-06-06 | Merck & Co. Inc. | Methods of treating bone diseases by administration of a cysteine proteinase inhibitor |
| AU5123196A (en) * | 1995-03-31 | 1996-10-16 | Nippon Chemiphar Co. Ltd. | Bisphosphonic acid derivatives |
| US5733911A (en) * | 1996-01-26 | 1998-03-31 | Hitachi Chemical Co., Ltd. | Method for inducing death of neoplastic cells using piperazne derivatives |
-
1996
- 1996-04-01 PT PT96907747T patent/PT826681E/pt unknown
- 1996-04-01 ES ES96907747T patent/ES2184855T3/es not_active Expired - Lifetime
- 1996-04-01 CN CN96194051A patent/CN1087295C/zh not_active Expired - Fee Related
- 1996-04-01 DK DK96907747T patent/DK0826681T3/da active
- 1996-04-01 DE DE69624235T patent/DE69624235T2/de not_active Expired - Lifetime
- 1996-04-01 EA EA199800181A patent/EA000438B1/ru not_active IP Right Cessation
- 1996-04-01 EP EP96907747A patent/EP0826681B1/en not_active Expired - Lifetime
- 1996-04-01 US US08/930,509 patent/US5843992A/en not_active Expired - Lifetime
- 1996-04-01 CA CA002217051A patent/CA2217051C/en not_active Expired - Fee Related
- 1996-04-01 AU AU51232/96A patent/AU716620B2/en not_active Ceased
- 1996-04-01 KR KR1019970706889A patent/KR100381275B1/ko not_active IP Right Cessation
- 1996-04-01 AT AT96907747T patent/ATE225781T1/de active
- 1996-04-01 WO PCT/JP1996/000889 patent/WO1996030354A1/ja active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2217051C (en) | 2006-05-30 |
| EA000438B1 (ru) | 1999-08-26 |
| DE69624235T2 (de) | 2003-06-26 |
| ATE225781T1 (de) | 2002-10-15 |
| WO1996030354A1 (fr) | 1996-10-03 |
| PT826681E (pt) | 2003-02-28 |
| ES2184855T3 (es) | 2003-04-16 |
| EP0826681A1 (en) | 1998-03-04 |
| KR100381275B1 (ko) | 2003-08-19 |
| CA2217051A1 (en) | 1996-10-03 |
| AU716620B2 (en) | 2000-03-02 |
| CN1185151A (zh) | 1998-06-17 |
| KR19980703485A (ko) | 1998-11-05 |
| DE69624235D1 (de) | 2002-11-14 |
| US5843992A (en) | 1998-12-01 |
| EP0826681B1 (en) | 2002-10-09 |
| AU5123296A (en) | 1996-10-16 |
| CN1087295C (zh) | 2002-07-10 |
| EP0826681A4 (pt) | 1998-03-18 |
| EA199800181A1 (ru) | 1998-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600834D0 (en) | Quinazoline derivatives | |
| DE69201948T2 (de) | Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b. | |
| IL101860A0 (en) | Heterocyclic derivatives | |
| DK0826681T3 (da) | Epoxyravsyrederivater | |
| IL104154A0 (en) | Saccharin derivatives,their preparation and pharmaceutical compositions containing them | |
| GR3036455T3 (en) | Atherosclerosis treatment | |
| ATE246196T1 (de) | Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon | |
| HU910681D0 (en) | Medical solution | |
| HU913793D0 (en) | Method for producing new hidantoine compounds | |
| AU667593B2 (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
| BR0212107A (pt) | Análogos da ciclopropil e da ciclobutil epotilona | |
| FI102896B1 (fi) | Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi | |
| MY103790A (en) | Novel compound for the treatment of several bone affecting diseases | |
| DE3780015D1 (de) | Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| EP0822260A4 (en) | SUBSTANCE FA-70D, METHOD OF MANUFACTURE AND USES | |
| HU9203052D0 (en) | Method for treatment of hypertension | |
| DE69319356T2 (de) | Thiolderivate von Gallensäure | |
| JO1648B1 (en) | Nitrogen compounds |